Navigation Links
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Date:10/24/2007

COLLEGEVILLE, Pa., Oct. 24 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's supplemental New Drug Application (sNDA) for its first-in-class antibiotic Tygacil(R) (tigecycline) for the treatment of patients with community-acquired pneumonia (CAP). The FDA now will complete its review of the application. The FDA may approve or disapprove the application, request additional data or take other administrative actions.

"CAP is a serious respiratory disease that affects millions of Americans," says Gary L. Stiles, M.D., Executive Vice President, Chief Medical Officer, Wyeth Pharmaceuticals. "The acceptance of this sNDA is an important event as it brings Wyeth closer to providing physicians with a new option for the treatment of CAP."

The sNDA submission included integrated data from two investigational clinical studies that included 846 patients. Study data showed that Tygacil cured 89.7 percent of patients hospitalized with CAP, and levofloxacin - an existing treatment option for CAP - cured 86.3 percent of studied patients. The most common adverse events for Tygacil were nausea (24.3 percent), vomiting (16.0 percent) and abdominal pain (5.7 percent). The discontinuation rates due to adverse events for Tygacil and levofloxacin were similar (6.1 percent and 8.3 percent, respectively).

"As antibiotic resistance continues to be a concern for many strains of the most common bacteria causing CAP, there is a growing need for new options," says Thomas File, M.D., Chief of Infectious Disease Services for Summa Health System in Akron, Ohio.

About Community-Acquired Pneumonia'/>"/>

SOURCE Wyeth
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. American Society of Clinical Oncology (ASCO) Accepts New Data on AVR118 for Publication in 2007 Abstract Book
2. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
3. New Quality Control Systems for Every Laboratory Application
4. Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor AP 12009 to be Presented
5. Antares Pharma Announces Positive Results from Application Site Study for Anturol
6. Idera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists at AACR
7. Point of Care Strep Tests Speed Treatment, Lower Costs
8. Rapid HIV Testing Increases Possibility of Treatment
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Sihuan Pharmaceutical ... the "Company"), a leading pharmaceutical company with the ... China,s prescription drug market, today ... and its subsidiaries (collectively the "Group") for the ... Financial HighlightsFor the Six months ended ...
(Date:8/27/2014)...  CVS Caremark (NYSE: CVS ) announced ... with MedStar Health, a leading health care system with ... the Washington, DC , region, which ... for patients. Through this clinical affiliation, MedStar Health patients ... counseling, chronic disease monitoring and wellness programs at CVS/pharmacy ...
(Date:8/27/2014)... , Aug. 27, 2014  UBM Medica US ... leading online community for medical imaging professionals, presents special ... for Medical Imaging Management,s 2014 Annual Meeting . ... coverage: , 11 Principles of Successful ... lead to greater profitability. , Why Don,t ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
(Date:8/28/2014)... (PRWEB) August 28, 2014 Coveros, ... today announced that it has partnered with InfoZen ... the performance start date of 2/4/2014 with U.S. ... Homeland Security (DHS) agency that oversees lawful immigration ... Coveros and InfoZen will automate the integration and ...
(Date:8/28/2014)... On September 1st, the National Pediculosis Association ... The goal is to help families and entire communities ... and without exposures to risky pesticides. The NPA ... exposures to pesticides should be limited as much as ... are often trivialized in the media, which present only ...
(Date:8/27/2014)... August 28, 2014 Aeroflow Healthcare ... acquire as part of a strategic expansion of ... positioned for taking ownership of new businesses through ... economies of scale. , Last week, the company ... Hometown Respiratory to increase service in the High ...
(Date:8/27/2014)... The report provides market analysis of ... Range Finder, LIDAR, 3D scanner, Laser Weapon, Dazzlers, Laser ... Laser Altimeter) by Domain (Aerospace, Defense and Homeland Security) ... by MarketsandMarkets, and its application in the aerospace and ... Laser Systems market is expected to register a CAGR ...
(Date:8/27/2014)... August 28, 2014 Recently, BambooIndustry.com, an innovative ... has announced that new bamboo panels are now ... providing deep discounts for clients worldwide. All people that place ... discounted rate, from 10 to 30 percent off. , ... new panels. “At the moment, all our new and old ...
Breaking Medicine News(10 mins):Health News:Coveros Partners with InfoZen on USCIS Transformation Integration Award 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:Aeroflow Healthcare Seeks Strategic Acquisition Opportunities 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2
... , MONDAY, Jan. 16 (HealthDay News) -- Lip ... talk, a new study reports. The finding challenges ... listening to people around them, according to the Florida Atlantic ... ways to diagnose autism spectrum disorders. Videos of women ...
... News) -- Children delivered by Cesarean section appear to be ... 3, a new study says. The findings support the ... than 37,000 participants in the Norwegian Mother and Child Cohort ... were delivered by planned or emergency C-section with those who ...
... (HealthDay News) -- The use of street drugs known as ... warns. It describes the first known case of necrotizing ... So-called bath salts are sold as synthetic powders that "often ... on Drug Abuse, which in February warned that injections might ...
... which is available free online at http://www.shef.ac.uk/FRAX/ , ... the world the online version alone is used to ... annually, with numbers growing steadily. The FRAX ... the input of Bone Mineral Density (BMD) values measured at ...
... a baseball game, the home plate umpire must instantaneously ... strike. In new research from the University of Chicago, ... these kinds of visual categories are encoded. While ... to quickly determine the category of a moving visual ...
... , SUNDAY, Jan. 15 (HealthDay News) -- When ... impulsive, saving less and borrowing more, according to a new ... when females are scarce, males become more competitive. They compete ... assistant professor of marketing at the Carlson School of Management ...
Cached Medicine News:Health News:Is Continued Lip-Reading an Early Sign of Autism? 2Health News:Children Born by C-Section at Slightly Higher Asthma Risk 2Health News:'Bath-Salts' Injection Leads to Flesh-Eating Disease 2Health News:Enormous growth in use of WHO Fracture Risk Assessment Tool 2Health News:Neural balls and strikes: Where categories live in the brain 2Health News:Neural balls and strikes: Where categories live in the brain 3Health News:Do Men Flash Cash to Find a Mate? 2
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
... GonoGen™ is a monoclonal ... for the confirmatory identification of ... not require isolated, viable or ... specimen and two minute rotation, ...
Rapid Test Kit...
... a novel device for the growth ... and Neisseria meningitidis. This product ... is easily transportable as a self-contained ... and examine the growth of organisms ...
Medicine Products: